
Shareholders Who Own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein
Investors who purchased or otherwise acquired shares of 3D Systems should contact the Firm prior to the August 12, 2025 lead plaintiff motion deadline.
PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION
The lawsuit alleges that during the Class Period, 3D Systems and certain of its executives made materially false and/or misleading statements and failed to disclose critical information, including:
The Company understated the impact of weakened customer spending and overstated its resilience amid challenging industry conditions. Revised milestone criteria in the United Partnership would adversely affect revenues from the Company's Regenerative Medicine Program. As a result, the Company's public statements were materially misleading.On March 26, 2025, 3D Systems reported disappointing financial results for Q4 and full-year 2024, including:
- Q4 2024 non-GAAP EPS of - $0.19, missing consensus by $0.08 per share; Sales revenue of $111 million, down 3.4% year-over-year, missing estimates by $4.17 million; Full-year 2024 revenue of $440.1 million, a 10% decline from the prior year, largely due to weaker hardware system sales; A $9 million Q4 revenue reduction related to changes in accounting estimates tied to its Regenerative Medicine Program and milestone refinements.
Following this news, shares of 3D Systems fell 20.96%, closing at $2.15 per share on March 27, 2025.
Subsequently, on May 12, 2025, 3D Systems issued a press release announcing its financial results for the first quarter ("Q1") of 2025.The Company attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty.
On this news, 3D Systems' stock price fell $0.68 per share, or 26.6%, to close at $1.87 per share on May 13, 2025.
PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION
Why Wolf Haldenstein Adler Freeman & Herz LLP ? :
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact:
- Phone: (800) 575-0735 or (212) 545-4774 Email: ... Contact Person: Gregory Stone, Director of Case and Financial Analysis
Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Bitget Launches CUSDT Perpetual Futures With 20X Leverage And Bot Trading Support
- Threshold Network's Tbtc Is Now Live On Sui: Ushering In A New Era For Bitcoin Defi
- Bitcoin Venture Studio Thesis* Acquires Lolli Rewards Platform To Kick Off BTC Ecosystem Expansion
- Blossom Fund Launches BLOS Token, Offering Retail Investors Access To A Professionally Managed Stock Portfolio
- Bit Origin Secures $500 Million Equity And Debt Facilities To Launch Dogecoin Treasury
- Primexbt Launches MT5 PRO Account With Superior Conditions For High-Volume Traders
Comments
No comment